These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 6315104)

  • 1. Presence of a dinucleotide fold in cholera toxin: possible approach to chemoprophylaxis?
    Dorai DT
    Biosci Rep; 1983 Sep; 3(9):879-86. PubMed ID: 6315104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of ADP-ribosyltransferase activity of cholera toxin by MDL 12330A and chlorpromazine.
    Bitonti AJ
    Biochem Biophys Res Commun; 1984 Apr; 120(2):700-6. PubMed ID: 6329180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Location and amino acid sequence around the ADP-ribosylation site in the cholera toxin active subunit A1.
    Lai CY; Xia QC; Salotra PT
    Biochem Biophys Res Commun; 1983 Oct; 116(1):341-8. PubMed ID: 6315008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholera toxin action on rabbit corpus luteum membranes: effects on adenylyl cyclase activity and adenosine diphospho-ribosylation of the stimulatory guanine nucleotide-binding regulatory component.
    Abramowitz J; Campbell AR
    Biol Reprod; 1985 Mar; 32(2):463-74. PubMed ID: 3921075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal and inhibition of cholera toxin-induced secretion in isolated rabbit ileum.
    Falk G; Freeman M; Marshall AT; Prenton E; Shiells RA; Slack I
    J Physiol; 1990 Feb; 421():399-409. PubMed ID: 2140861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyrotropin stimulation of the ADP-ribosyltransferase activity of bovine thyroid membranes.
    Vitti P; De Wolf MJ; Acquaviva AM; Epstein M; Kohn LD
    Proc Natl Acad Sci U S A; 1982 Mar; 79(5):1525-9. PubMed ID: 6280188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of high-specific-activity subunits of cholera toxin by reversed-phase high-performance liquid chromatography.
    Pearson SD; Dixon JD; Nothwehr SF; Kurosky A
    J Chromatogr; 1986 May; 359():413-21. PubMed ID: 3016001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotinamide adenine dinucleotide (NAD) and its metabolites inhibit T lymphocyte proliferation: role of cell surface NAD glycohydrolase and pyrophosphatase activities.
    Bortell R; Moss J; McKenna RC; Rigby MR; Niedzwiecki D; Stevens LA; Patton WA; Mordes JP; Greiner DL; Rossini AA
    J Immunol; 2001 Aug; 167(4):2049-59. PubMed ID: 11489987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site-specific mutagenesis of the catalytic subunit of cholera toxin: substituting lysine for arginine 7 causes loss of activity.
    Burnette WN; Mar VL; Platler BW; Schlotterbeck JD; McGinley MD; Stoney KS; Rohde MF; Kaslow HR
    Infect Immun; 1991 Nov; 59(11):4266-70. PubMed ID: 1937784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of adenylate cyclase by heat-labile Escherichia coli enterotoxin. Evidence for ADP-ribosyltransferase activity similar to that of choleragen.
    Moss J; Richardson SH
    J Clin Invest; 1978 Aug; 62(2):281-5. PubMed ID: 209060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of diphtheria toxin bound to nicotinamide adenine dinucleotide.
    Bell CE; Eisenberg D
    Biochemistry; 1996 Jan; 35(4):1137-49. PubMed ID: 8573568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Migrating action-potential complex activity in absence of fluid production is produced by B subunit of cholera enterotoxin.
    Sinar DR; Charles LG; Burns TW
    Am J Physiol; 1982 Jan; 242(1):G47-51. PubMed ID: 7058898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of cholera toxin by human milk fractions and sialyllactose.
    Idota T; Kawakami H; Murakami Y; Sugawara M
    Biosci Biotechnol Biochem; 1995 Mar; 59(3):417-9. PubMed ID: 7766178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADP-ribosyl transferase activity of cholera toxin polypeptide A1 and the effect of limited trypsinolysis.
    Lai CY; Cancedda F; Duffy LK
    Biochem Biophys Res Commun; 1981 Oct; 102(3):1021-7. PubMed ID: 6272811
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanism of action of choleragen.
    Vaughan M; Moss J
    J Supramol Struct; 1978; 8(4):473-88. PubMed ID: 214641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effects of nicotinic acid and nicotinamide on cholera toxin-induced secretion in rabbit ileum.
    Briend A; Nath SK; Heyman M; Desjeux JF
    J Diarrhoeal Dis Res; 1993 Jun; 11(2):97-100. PubMed ID: 8409288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A note on the predicted secondary structures of the active chains of cholera and diphtheria toxins.
    Duffy LK; Lai CY
    Toxicon; 1986; 24(2):204-6. PubMed ID: 3010508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of NAD+ by cholera toxin.
    Galloway TS; van Heyningen S
    Biochem J; 1987 May; 244(1):225-30. PubMed ID: 2821999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential cholera-toxin- and pertussis-toxin-catalysed ADP-ribosylation of G-proteins coupled to formyl-peptide and leukotriene B4 receptors.
    Schepers TM; McLeish KR
    Biochem J; 1993 Jan; 289 ( Pt 2)(Pt 2):469-73. PubMed ID: 8380997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement by cholera toxin of IgA secretion from intestinal crypt epithelium.
    Hamilton SR; Keren DF; Boitnott JK; Robertson SM; Yardley JH
    Gut; 1980 May; 21(5):365-9. PubMed ID: 7429298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.